Aurobindo Pharma: M. R. Kumar Reappointed Independent Director
Aurobindo Pharma Ltd announced the re-appointment of Mr. M. R. Kumar as a Non-executive and Independent Director for a second term of five years, effective April 1, 2027. This decision was approved by the Board of Directors following a recommendation from the Nomination and Remuneration Committee. The re-appointment is subject to shareholder approval via postal ballot. Mr. Kumar's current term concludes on March 31, 2027. He is not related to any company directors or key managerial personnel and is not debarred from holding a directorial position by any regulatory authority. Mr. Kumar brings extensive experience from his tenure as Chairman of LIC of India and various leadership roles within the insurance sector, as well as directorships in other financial institutions.
Key Highlights
- Mr. M. R. Kumar re-appointed as Independent Director for a second 5-year term.
- Re-appointment effective from April 1, 2027, subject to member approval.
- Director has extensive experience in financial services and insurance sectors.
- No relationship with existing directors or KMPs.
- Director is not debarred by any regulatory authority.
Price Impact
More from AUROPHARMA